TY - JOUR
T1 - Review of renal cell carcinoma with rhabdoid features with focus on clinical and pathobiological aspects
AU - Kuroda, Naoto
AU - Karashima, Takashi
AU - Inoue, Keiji
AU - Kasajima, Atsuko
AU - Ohe, Chisato
AU - Kawakami, Fumi
AU - Mikami, Shuji
AU - Matsuura, Keiko
AU - Moriyama, Masatsugu
AU - Nagashima, Yoji
AU - Petersson, Fredrik
AU - Lopez, Jose I.
AU - Cohen, Ronald J.
AU - Michal, Michal
AU - Hes, Ondrej
N1 - Publisher Copyright:
© 2015 Versalius University Medical Publisher. All rights reserved.
PY - 2015
Y1 - 2015
N2 - Rhabdoid morphology in renal cell carcinoma (RCC) may, like sarcomatoid change,be perceived as a type of dedifferentiation, and is a poor prognostic factor. Histologically,rhabdoid neoplastic cells are round to polygonal cells with globular eosinophiliccytoplasmic inclusions and eccentric vesicular nuclei and enlarged nucleoli.All types of RCC, including clear cell, papillary, chromophobe, collecting ductcarcinoma, renal medullary carcinoma, acquired cystic disease-associated RCC,ALK-positive renal cancer and unclassified RCC, may display a variably prominentrhabdoid phenotype. Immunohistochemically, the cytoplasm of rhabdoid cellsshows positivity for vimentin and/or cytokeratin. Ultrastructurally, cytoplasmicwhorls/aggregates of intermediate filaments correspond to light microscopicallyobserved inclusions. Genetically, a previous report suggests that combined loss ofBAP1 and PBRM1 may be associated with rhabdoid morphology. As with sarcomatoidchange, pathologists should describe, estimate and state the proportion oftumor cells with a rhabdoid phenotype in the routine pathology report of RCC.
AB - Rhabdoid morphology in renal cell carcinoma (RCC) may, like sarcomatoid change,be perceived as a type of dedifferentiation, and is a poor prognostic factor. Histologically,rhabdoid neoplastic cells are round to polygonal cells with globular eosinophiliccytoplasmic inclusions and eccentric vesicular nuclei and enlarged nucleoli.All types of RCC, including clear cell, papillary, chromophobe, collecting ductcarcinoma, renal medullary carcinoma, acquired cystic disease-associated RCC,ALK-positive renal cancer and unclassified RCC, may display a variably prominentrhabdoid phenotype. Immunohistochemically, the cytoplasm of rhabdoid cellsshows positivity for vimentin and/or cytokeratin. Ultrastructurally, cytoplasmicwhorls/aggregates of intermediate filaments correspond to light microscopicallyobserved inclusions. Genetically, a previous report suggests that combined loss ofBAP1 and PBRM1 may be associated with rhabdoid morphology. As with sarcomatoidchange, pathologists should describe, estimate and state the proportion oftumor cells with a rhabdoid phenotype in the routine pathology report of RCC.
KW - Poor prognosis
KW - Renal cell carcinoma
KW - Rhabdoid features
UR - http://www.scopus.com/inward/record.url?scp=84929409541&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929409541&partnerID=8YFLogxK
U2 - 10.5114/pjp.2015.51147
DO - 10.5114/pjp.2015.51147
M3 - Review article
C2 - 26017874
AN - SCOPUS:84929409541
SN - 1233-9687
VL - 66
SP - 3
EP - 8
JO - Polish Journal of Pathology
JF - Polish Journal of Pathology
IS - 1
ER -